## Abstract In human breast cancer, mutations in the __p53__ gene are associated with poor prognosis. However, analysis of patient data so far did not clarify, whether missense point mutations in the __p53__ gene, in addition to causing loss of wild‐type p53 function, also confer a gain of function
p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis
✍ Scribed by Wing-pui Tsang; Franz Y.F. Ho; Kwok-pui Fung; Siu-kai Kong; Tim-tak Kwok
- Book ID
- 102862155
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- French
- Weight
- 719 KB
- Volume
- 114
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Mutation of tumor suppressor p53 gene gains new function in regulation of DNA damage‐induced apoptotic response in tumor cells, which may lead to a poor response in cancer chemotherapy and radiotherapy. Transfection of mutant p53 (R175H) to p53‐null osteosarcoma Saos‐2 cells suppressed apoptosis induced by doxorubicin (DOX), cisplatin and gamma radiation. Downregulation of caspase‐3 but not ‐8 or ‐9 basal protein levels was also observed in Saos‐2 cells transfected with p53‐R175H. After 48 hr of DOX treatment, the rate of procasapse‐3 activation into 17 kDa active form was about 3‐fold higher in the control cells than that in the p53‐R175H counterpart. Gene silencing of p53‐R175H expression by p53 siRNA upregulate the procaspase‐3 protein level and restored DOX‐induced apoptosis in p53‐R175H cells. Our results suggest that p53‐R175H mutation may gain new function in decreasing DOX‐induced apoptotic response through suppression of caspase‐3 level and its activation. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Regulation and function of PI 3K/Akt and mitogen‐activated protein kinases (MAPKs) in doxorubicin‐induced cell death were investigated in human lung adenocarcinoma cells. Doxorubicin induced dose‐dependent apoptosis of human lung adenocarcinoma NCI‐H522 cells. Prior to cell death, both